These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8362602)

  • 1. Management of hemosiderosis complicated by coexistent anemia with recombinant human erythropoietin and phlebotomy.
    Bilgrami S; Bartolomeo A; Synnott V; Rickles FR
    Acta Haematol; 1993; 89(3):141-3. PubMed ID: 8362602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of hemosiderosis with regular phlebotomy and recombinant human erythropoietin. Case report and ferrokinetic studies.
    Hotta T; Inoue C; Tsushita K; Miura Y; Saito H
    Acta Haematol; 1991; 86(4):214-6. PubMed ID: 1805491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients.
    Agroyannis B; Koutsicos D; Tzanatou-Exarchou H; Varsou-Papadimitriou E; Kapetanaki A; Yatzidis H
    Int J Artif Organs; 1991 Jul; 14(7):403-6. PubMed ID: 1889892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
    Lazarus JM; Hakim RM; Newell J
    Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human recombinant erythropoietin and phlebotomy in the treatment of iron overload in uremic patients.
    Chen KS; Leu ML; Huang CC
    Changgeng Yi Xue Za Zhi; 1995 Sep; 18(3):248-53. PubMed ID: 8521335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of nuclear magnetic resonance imaging in monitoring total body iron in hemodialysis patients with hemosiderosis treated with erythropoietin and phlebotomy.
    Chan PC; Liu P; Cronin C; Heathcote J; Uldall R
    Am J Kidney Dis; 1992 May; 19(5):484-9. PubMed ID: 1585939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of serious iron overload in a chronic hemodialysis patient by recombinant human erythropoietin and removal of red blood cells: confirmation by follow-up liver biopsy.
    Onoyama K; Nakamura S; Yamamoto M; Kawadoko T; Nanishi F; Komoda T; Murai K; Fujishima M
    Nephron; 1990; 56(3):325-8. PubMed ID: 2077417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of iron overload with combination of recombinant human erythropoietin and phlebotomy].
    Nagafuji K; Shibuya T; Yanagida K; Okamura T; Nakamura M; Harada M; Niho Y; Yamano Y
    Rinsho Ketsueki; 1991 Jul; 32(7):791-5. PubMed ID: 1920844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin].
    Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M
    Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a seven-year-old child with end-stage renal disease and hemosiderosis by recombinant human erythropoietin.
    Burghard R; Leititis J; Pallacks R; Scigalla P; Brandis M
    Contrib Nephrol; 1988; 66():139-48. PubMed ID: 3391028
    [No Abstract]   [Full Text] [Related]  

  • 11. Erythropoietin--advent of a new treatment.
    Winearls C
    Practitioner; 1987 Oct; 231(1436):1269-73. PubMed ID: 3333088
    [No Abstract]   [Full Text] [Related]  

  • 12. Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
    De Gobbi M; Pasquero P; Brunello F; Paccotti P; Mazza U; Camaschella C
    Haematologica; 2000 Aug; 85(8):865-7. PubMed ID: 10942934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy.
    McCarthy JT; Johnson WJ; Nixon DE; Jenson BM; Moyer TP
    J Lab Clin Med; 1989 Aug; 114(2):193-9. PubMed ID: 2754306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of anemia with decreasing hepcidin levels following valve replacement for severe tricuspid regurgitation.
    Suzuki T; Hanawa H; Ding L; Ito M; Kashimura T; Obata H; Hu YH; Jiao S; Namura O; Kodama M
    Eur J Haematol; 2012 Jun; 88(6):551-2. PubMed ID: 22420462
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory anemia in a patient with allergy to intravenous iron drugs.
    Fishbane S
    Kidney Int; 2006 May; 69(10):1910-3. PubMed ID: 16625145
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of anemia in myelodysplastic syndromes with recombinant human erythropoietin].
    Rodríguez JN; Prados D; Martino ML; Muñiz R
    Sangre (Barc); 1993 Aug; 38(4):340-1. PubMed ID: 8235952
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: a pilot, open-label study with neurophysiological measurements.
    Créange A; Lefaucheur JP; Balleyguier MO; Galactéros F
    Neurophysiol Clin; 2013 Dec; 43(5-6):303-12. PubMed ID: 24314757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac hemolysis and anemia refractory to erythropoietin: on anemia in dialysis patients.
    Evers J
    Nephron; 1995; 71(1):108. PubMed ID: 8538832
    [No Abstract]   [Full Text] [Related]  

  • 19. Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin.
    Fridge JL; Vichinsky EP
    J Pediatr; 1998 May; 132(5):871-3. PubMed ID: 9602203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine abnormalities in hemodialysis patients with iron overload: reversal with iron depletion.
    el-Reshaid K; Seshadri MS; Hourani H; Qurtom M; Kamel H
    Nutrition; 1995; 11(5 Suppl):521-6. PubMed ID: 8748213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.